disulfiram has been researched along with Acute Edematous Pancreatitis in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disulfiram (DSF) is an FDA-proved drug with potential therapeutic effects on inflammatory diseases." | 5.91 | Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis. ( Dai, C; Huang, KL; Huang, QY; Lin, ZH; Liu, YY; Shen, Y; Yu, XY; Yuan, L; Zhang, QY; Zhang, R, 2023) |
| "Severe acute pancreatitis (SAP) is characterized by pancreatic and systemic inflammation and persistent organ failure." | 5.91 | Disulfiram relieves severe acute pancreatitis by inhibiting GSDMD-dependent NETs formation. ( Ding, Z; Han, CQ; Ling, X; Nie, C; Sheng, LP, 2023) |
| "Disulfiram (DSF) is an FDA-proved drug with potential therapeutic effects on inflammatory diseases." | 1.91 | Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis. ( Dai, C; Huang, KL; Huang, QY; Lin, ZH; Liu, YY; Shen, Y; Yu, XY; Yuan, L; Zhang, QY; Zhang, R, 2023) |
| "Severe acute pancreatitis (SAP) is characterized by pancreatic and systemic inflammation and persistent organ failure." | 1.91 | Disulfiram relieves severe acute pancreatitis by inhibiting GSDMD-dependent NETs formation. ( Ding, Z; Han, CQ; Ling, X; Nie, C; Sheng, LP, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, QY | 1 |
| Zhang, R | 1 |
| Zhang, QY | 1 |
| Dai, C | 1 |
| Yu, XY | 1 |
| Yuan, L | 1 |
| Liu, YY | 1 |
| Shen, Y | 1 |
| Huang, KL | 1 |
| Lin, ZH | 1 |
| Ling, X | 1 |
| Nie, C | 1 |
| Sheng, LP | 1 |
| Han, CQ | 1 |
| Ding, Z | 1 |
| Kast, RE | 1 |
| Honda, S | 1 |
| Fujioka, T | 1 |
| Shiota, K | 1 |
| Fujiyama, K | 1 |
| Kubota, T | 1 |
| Murakami, K | 1 |
| Nasu, M | 1 |
1 review available for disulfiram and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery.
Topics: Acute Disease; Animals; Antihypertensive Agents; Captopril; Caspase Inhibitors; Disulfiram; Drug Syn | 2008 |
3 other studies available for disulfiram and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis.
Topics: Acinar Cells; Acute Disease; Animals; Ceruletide; Disulfiram; Mice; Molecular Docking Simulation; Ne | 2023 |
Disulfiram relieves severe acute pancreatitis by inhibiting GSDMD-dependent NETs formation.
Topics: Acute Disease; Animals; Disulfiram; Extracellular Traps; Inflammation; Mice; Pancreatitis | 2023 |
Effects of ethanol on the pancreas of disulfiram-treated rats.
Topics: Acetaldehyde; Acute Disease; Administration, Oral; Amylases; Animals; Disease Models, Animal; Disulf | 1995 |